For decades India was known for making low cost generic medicines through reverse engineering. Now Indian pharmaceutical innovation has stunned the world with two novel antibiotics at a time when the global pipeline for new antibiotics is drying up. The breakthrough offers fresh hope against deadly drug resistant superbugs. NDTV’s Science Editor Pallava Bagla spoke exclusively to Dr Radha Rangarajan, Director, Central Drug Research Institute, Lucknow on how this discovery can defeat superbugs.
